Rat lymph chylomicrons and chylomicron remnants were treated with trypsin or Pronase. The ability of the resulting apoprotein-free lipoproteins to be taken up by the isolated perfused rat liver, and to bind to isolated rat liver membranes, was examined. Compared with control lipoproteins, the apoprotein-free chylomicrons and remnants retained unaltered their capacity to be differentiated by the intact liver and by the isolated membranes. Further, control remnants and apoprotein-free remnants competed for binding to the isolated membranes. We conclude that apoproteins are not required for the hepatic differentiation between chylomicrons and remnants, and suggest that the lipoprotein phospholipids may play a direct role in this process.
INTRODUCTION
The removal of chylomicrons from the circulation is a complex process that begins with their partial degradation in the vascular space, and ends with the uptake of the resulting particles, the chylomicron remnants, by the liver (Redgrave, 1970) . There is considerable evidence that hepatic uptake of remnants occurs by a receptor-mediated process (Mahley et al., 1989) , but many aspects of this process remain to be fully elucidated. Specifically, the identity of the receptor, and the requisite compositional changes in the chylomicron which allow recognition of the resulting remnant by the receptor, are not yet established (Mahley et al., 1989; Soutar, 1989) . It is widely believed that remnant apoprotein E is the ligand for the hepatic receptor (Mahley et al., 1989) , but that effective ligand-receptor interaction does not occur until the apoprotein E/C ratio of the particle is sufficiently increased by the loss of apoprotein C during the chylomicron degradation (Windler et al., 1980a,b; Shelburne et al., 1980; Quarfordt et al., 1982; Windler & Havel, 1985; Weisgraber et al., 1990; Kowal et al., 1990) . Work from our laboratory has shown, however, that chylomicrons and remnants which have been modified so as to have similar apoprotein E/C ratios are still differentiated by the liver (Borensztajn & Kotlar, 1984) .
In addition to the changes in relative apoprotein concentrations, the generation of remnants is also accompanied by modification in phospholipid composition (Redgrave & Small, 1979; Tall et al., 1979; Landin & Nilsson, 1984) . We have examined whether these phospholipid alterations, rather than changes in the apoprotein E/C ratio, might account for the hepatic differentiation of the lipoproteins. We have demonstrated that chylomicrons treated in vitro with phospholipase A2 (Borensztajn et Borensztajn & Kotlar, 1981) or with hepatic lipase (Borensztajn et al., 1988) , which causes little or no change in apoprotein composition, are transformed into 'remnants' that can be readily removed from circulation by the liver and can compete with endogenous remnants for uptake by hepatocytes (Borensztajn et al., 1988 (Borensztajn .et al., 1985) . After removal of the floating chylomicron layer, the remaining lipoproteins were spun further in the ultracentrifuge at 80000 g for 16 h at 15°C and the floating small chylomicrons were harvested. Before being used for membranebinding assays, the chylomicrons were then purified by gelpermeation chromatography as previously described (Borensztajn et al., 1985) .
Preparation of remnants
For the preparation of chylomicron remnants, post-heparin plasma was obtained by bleeding male Sprague-Dawley rats (350-450 g) 10 min after they had been injected intravenously with 60 i.u. ofheparin/kg. The post-heparin plasma was collected after centrifugation of the blood at 2000 g for 20 min at 5 'C. The small chylomicrons were then incubated with the postheparin plasma (3 mg of triacylglycerols/ml) for 4 h at 37 'C. The density of the incubation mixture was then adjusted to 1.019 g/ml by addition of NaCl. This incubation mixture was then layered under an equal volume of an NaCl solution of density 1.019 g/ml and spun at 80000 g for 18 h at 15 'C in a Beckman model L5-75 ultracentrifuge in a SW 27 rotor. The floating layer of remnants was harvested, and purified by gelpermeation chromatography as previously described (Borensztajn et al., 1985) . With this procedure, 70-800% of the chylomicron triacylglycerols were hydrolysed.
Liver perfusion
The technique for liver perfusion was essentially as previously described (Borensztajn & Kotlar, 1984) . The basic perfusion medium was Krebs-Ringer bicarbonate buffer (pH 7.4), continuously gassed with 02/C02 (19: 1), containing 3 % (w/v) BSA (Sigma) and 1 mg of glucose/ml. Chylomicrons or remnants were added to 30 ml of this medium at a concentration of 9 jig of cholesterol/ml. Livers were first perfused without recirculation for 5 min with the basic medium to remove blood from the preparation. This was followed by a 4 min recirculatory perfusion with the various lipoprotein preparations, and finally a 2 min perfusion without recirculation with the basic medium to wash out lipoproteins that might have been trapped in the sinusoidal spaces. After the washing, the livers were blotted and weighed, and 1 g samples were taken for radioactivity measurement as previously described (Borensztajn & Kotlar, 1984 Competition was carried out by adding 100 ,ug of membrane protein to 1.5 ml polyallomer tubes (Beckman) containing labelled remnants and buffer. Unlabelled remnants were added 2 min later and the mixture was incubated at 37°C for 60 min. The final volume of each assay was 0.5 ml. Blanks containing no membranes were also included in all experiments. After incubation, the tubes were centrifuged in a TL-100 ultracentrifuge (Beckman), in a TLA-45 rotor, at 125 000 g for 20 min at 25 'C.
The supernatant was replaced with fresh buffer and the tubes were re-centrifuged under the above conditions. After centrifugation, the supernatant was discarded and the bottom of the tube was cut off into a counting vial containing 5 ml of scintillation fluid. The vials were then sonicated, as described above, and counted for radioactivity.
Other procedures
Treatments ofchylomicrons and remnants with trypsin (Sigma) or Pronase (Sigma) were as previously described (Borensztajn et (Marsh, 1986) , the possibility could not be ruled out that the proteinase-treated remnants re-acquired apoprotein E before being taken up by the hepatocytes. However, for this explanation to be valid, it is necessary to postulate either that the proteinase-treated chylomicrons, which were poorly taken up by the liver, did not acquire apoprotein E, or that they acquired lesser amounts of this apoprotein than the proteinase-treated remnants. An alternative explanation is that, unlike remnants, the proteinase-treated chylomicrons acquired apoprotein E in a conformation that does not allow its recognition by the receptor.
To avoid these problems of potential apoprotein E contamination of the lipoproteins in the intact liver, we examined the ability ofcontrol and apoprotein-free chylomicrons and remnants to bind to isolated liver membranes, an experimental system that has been successfully used in the investigation of lipoprotein receptors (Carella & Cooper, 1979; Cooper et al., 1982; Kita et al., 1982; Hui et al., 1984; Windler et al., 1988; Nagata et al., 1988) . Fig. 1(a) Fig. 1(b) shows the results obtained when chylomicrons and remnants that had been pre-treated with trypsin were incubated with the isolated membranes. It is apparent that the apoprotein-free remnants retained unchanged 1991 Vol. 279 their abiIity to bind to the isolated membranes. Under the conditions used, all apoproteins from the chylomicrons and the remnants, including apoprotein E, were digested by the proteinase, as previously reported (Borensztajn & Kotlar, 1984) . It is possible that, after trypsin digestion, apoprotein E fragments remained attached to the surface ofthe lipoproteins. It is unlikely, however, that such fragments would mediate the binding of remnants to the membranes or, in that eventuality, that they would do so as efficiently as the intact apoprotein. Bradley & Gianturco (1986) reported that trypsin treatment of very-lowdensity lipoproteins caused the degradation of their apoprotein E and, as a result, the complete loss of their ability to bind to fibroblast receptors. Bates et al. (1987) reported that trypsin digestion of apoprotein E on the surface of fl-very-low-density lipoproteins (/J-VLDL) abolished the ability of these lipoprotein remnants to be recognized by receptors on the surface of macrophages. Connelly et al. (1988) reported that treatment of ,-VLDL with trypsin abolished its ability to displace low-density lipoprotein from fibroblasts.
To exclude further the possibility that apoprotein E fragments might have mediated the binding of the remnants to the membranes, we repeated the binding experiments, using remnants made apoprotein-free by treatment with Pronase. The use of Pronase, a mixture of proteolytic enzymes isolated from Streptomyces griseus, ensured a more extensive digestion of the apoproteins. In a previous report, no apoprotein B fragments were detected on the surface of chylomicrons after their treatment with Pronase (Borensztajn et al., 1982) . The results in Fig. l(c) show that, like the intact (Fig. la) or the trypsin-treated (Fig. lb) remnants, the Pronase-treated particles retained unchanged their ability to bind to the membranes. If binding were mediated by fragments of apoprotein E generated by the mixture of nonspecific proteinases (Pronase), it would be necessary to postulate (a) that such fragments resembled those generated by trypsin, and (b) that they retained fully the binding ability of intact apoprotein E.
Because the remnants were double-labelled with [14C]fatty acids and [3H]cholesterol, it was possible to determine that in all cases the remnants bound as a unit to the membranes. In the experiment shown in Fig. l(c) , the 14C/3H ratio of the remnants added to the isolated membranes was 0.1 1, and the ratio of the radioactivity recovered associated with the membranes was 0.10+0.01 (mean+s.D., n = 15). To determine whether the apoprotein-free and control remnants shared the same mechanism of binding to the membranes, we compared the ability of unlabelled control and trypsin-treated remnants to compete with [3H]cholesterol-labelled remnants for binding to the membranes. Fig. 2 shows that both types of particles effectively displaced the binding of the labelled remnants. Although only a 60% displacement was observed with an 8-fold excess of unlabelled remnants, the curves in Fig. 1 that apoprotein E-deficient remnants did not bind to receptors on isolated dog liver membranes, whereas chylomicron remnants containing this apoprotein bound with high affinity. It is noteworthy, however, that in that study (Hui et al., 1984 ) the control and apoprotein E-deficient remnants were prepared by different methods, and, although the differences in their binding to the membranes were attributed solely to differences in their apoprotein E content, the particles also differed significantly in their lipid composition. For example, the phospholipid/triacylglycerol ratio of the control remnants was 0.26, whereas in the remnants deficient in apoprotein E this ratio was 0.44. These differences in phospholipid content of the remnants are pertinent, in light of the proposition that phospholipids play a major role in the hepatic uptake of remnants (Borensztajn & Kotlar, 1990 ; see also the Introduction). In another study, Arbeeny & Rifici (1984) reported that remnants deficient in apoprotein E were cleared by the isolated perfused liver less efficiently than control remnants. However, in that study the comparison was also carried out between control and apoprotein E-deficient remnants that had been prepared by quite different methods. Whereas apoprotein E-rich remnants were prepared from chylomicrons injected into normal hepatectomized rats, the apoprotein E-deficient remnants were prepared by using hepatectomized ethinyloestradiol-treated rats injected with chylomicrons obtained from animals that had also been treated with that sterol. It is known that the pharmacological dose of ethinyloestradiol used in that study has significant effects in the overall composition of plasma lipoproteins, including chylomicrons (Davis & Roheim, 1978; Chao et al., 1979; Krause et al., 1981) . It is therefore conceivable that the reported differences in the hepatic clearance of remnants (Arbeeny & Rifici, 1984) might be explained by factors other than their apoprotein E content. A role for apoprotein E in the hepatic recognition of remnants has also been proposed, on the strength of observations that addition of this apoprotein to lipoproteins and lipid emulsions stimulates the hepatic clearance of these particles (Shelburne et al., 1980; Windler & Havel, 1985) . Several proteins capable of binding apoprotein E have been described in a variety of cells. One such protein found in liver cell membranes, the low-densitylipoprotein-receptor-related protein (LRP), has been shown to bind cholesterol-rich remnants (/J-VLDL) in vitro, and it has been proposed to function as the hepatic remnant receptor in vivo Kowal et al., 1990; Weisgraber et al., 1990) . It is noteworthy, however, that LRP binds fl-VLDL only when an excess of apoprotein E is added to these lipoproteins. It is conceivable that LRP, or other apoprotein E-binding proteins, may facilitate the hepatic clearance of lipoproteins and emulsions artificially enriched with apoprotein E (Shelburne et al., 1980; Windler & Havel, 1985) . However, the present results with the isolated perfused rat liver and isolated liver membranes suggest that the hepatic clearance of remnants from circulation may occur by an apoprotein E-independent mechanism. We have previously demonstrated that phospholipids play an important role in the uptake of remnants by the liver, and proposed that they function by modulating the binding of apoprotein E to the putative remnant receptor (Borensztajn & Kotlar, 1984 Borensztajn et al., 1988) . In light of the present study, it is possible that phospholipids function as main determinants of remnant recognition by the liver, independently of apoprotein E.
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